People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,120.50GBp
1 Jul 2015
Change (% chg)

-- (--)
Prev Close
4,120.50p
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,698,190
52-wk High
4,931.68p
52-wk Low
4,019.00p

Search Stocks

Dobber, Ruud 

Mr. Ruud Dobber is the Executive Vice President, Europe of AstraZeneca PLC., since January 2013 and leads AstraZeneca’s commercial operations in Europe. In this capacity, Ruud is responsible for sales, marketing and commercial operations across AstraZeneca’s businesses in the 27 EU member states. Ruud joined AstraZeneca in 1997 and has held a number of senior commercial roles including Regional Vice- President of AstraZeneca’s European, Middle East and African division and Regional Vice- President for the Group’s Asia Pacific region. Since 2012, Ruud has been an Executive Committee Member of EFPIA. In 2011, Ruud was the Chairman of the Asia division of Pharmaceutical Research and Manufacturers of America. Ruud commenced his career as a scientist, researching in the field of immunology and ageing. He holds a doctorate in immunology from the University of Leiden in the Netherlands.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Leif Johansson

540,000

Pascal Soriot

3,344,000

Marc Dunoyer

296,000

Ruud Dobber

--

Caroline Hempstead

--

Paul Hudson

--
As Of  30 Dec 2013
Search Stocks